BBA
GHDX
Baker Bros. Advisors’s Genomic Health, Inc. GHDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-9,244,665
| Closed | -$627M | – | 116 |
|
2019
Q3 | $627M | Sell |
9,244,665
-16,257
| -0.2% | -$1.1M | 4.27% | 7 |
|
2019
Q2 | $539M | Sell |
9,260,922
-938,021
| -9% | -$54.6M | 3.66% | 8 |
|
2019
Q1 | $714M | Sell |
10,198,943
-1,545,067
| -13% | -$108M | 4.57% | 7 |
|
2018
Q4 | $756M | Sell |
11,744,010
-2,046,960
| -15% | -$132M | 6.19% | 5 |
|
2018
Q3 | $968M | Buy |
13,790,970
+396
| +0% | +$27.8K | 6.38% | 5 |
|
2018
Q2 | $695M | Buy |
13,790,574
+638
| +0% | +$32.2K | 5.22% | 6 |
|
2018
Q1 | $431M | Buy |
13,789,936
+8,834
| +0.1% | +$276K | 3.66% | 7 |
|
2017
Q4 | $471M | Buy |
13,781,102
+622
| +0% | +$21.3K | 4.09% | 6 |
|
2017
Q3 | $442M | Buy |
13,780,480
+614
| +0% | +$19.7K | 3.59% | 6 |
|
2017
Q2 | $449M | Buy |
13,779,866
+8,884
| +0.1% | +$289K | 3.92% | 6 |
|
2017
Q1 | $434M | Buy |
13,770,982
+680
| +0% | +$21.4K | 3.55% | 5 |
|
2016
Q4 | $405M | Hold |
13,770,302
| – | – | 3.97% | 7 |
|
2016
Q3 | $398M | Buy |
13,770,302
+101,436
| +0.7% | +$2.93M | 3.61% | 9 |
|
2016
Q2 | $354M | Buy |
13,668,866
+9,034
| +0.1% | +$234K | 3.71% | 9 |
|
2016
Q1 | $338M | Buy |
13,659,832
+568
| +0% | +$14.1K | 3.57% | 9 |
|
2015
Q4 | $481M | Buy |
13,659,264
+936
| +0% | +$32.9K | 3.98% | 8 |
|
2015
Q3 | $289M | Buy |
13,658,328
+730
| +0% | +$15.4K | 2.67% | 10 |
|
2015
Q2 | $380M | Buy |
13,657,598
+656
| +0% | +$18.2K | 3.33% | 10 |
|
2015
Q1 | $417M | Buy |
13,656,942
+624
| +0% | +$19.1K | 3.47% | 11 |
|
2014
Q4 | $437M | Buy |
13,656,318
+700
| +0% | +$22.4K | 4.46% | 8 |
|
2014
Q3 | $387M | Buy |
13,655,618
+716
| +0% | +$20.3K | 4.87% | 7 |
|
2014
Q2 | $374M | Buy |
13,654,902
+752
| +0% | +$20.6K | 4.58% | 7 |
|
2014
Q1 | $360M | Buy |
13,654,150
+3,315
| +0% | +$87.3K | 4.57% | 7 |
|
2013
Q4 | $400M | Hold |
13,650,835
| – | – | 5.63% | 7 |
|
2013
Q3 | $417M | Hold |
13,650,835
| – | – | 5.93% | 7 |
|
2013
Q2 | $433M | Buy |
+13,650,835
| New | +$433M | 8.56% | 3 |
|